IHS Chemical Week

Regions :: Southeast Asia :: Singapore

Roche Agrees to Buy Lonza's Singapore Manufacturing Facility

1:49 AM MDT | August 31, 2009 | Natasha Alperowicz

Lonza has announced that Genentech Singapore, a wholly-owned member of the Roche Group, has elected to exercise an option to purchase from Lonza its cell culture biologic manufacturing facility in Singapore for $290 million plus additional milestone payments of $70 million. The facility, which is mechanically completed, will be merged with Genentech Singapore's existing biologic manufacturing facility. As part of the integration between Roche's and Genentech's combined technical operations, the biotechnology production facilities in Singapore currently operating...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa